Press Releases
DefiniGEN licenses CRISPR-Cas9 gene editing technology
DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to...
Clinical Trials
Pharm-Olam is proud to have contributed to the execution and completion of Cablivi ivotal Phase III study
Pharm-Olam, a global, midsized CRO offering full-service clinical development solutions for oncology, infectious diseases and vaccines, and rare and orphan diseases, extends its congratulations...
Press Releases
BioBeat unveils 2018’s 50 Movers and Shakers
A new report released unveils 50 female leaders in healthcare business in the UK. Produced by BioBeat, 50 Movers and Shakers in BioBusiness 2018...
Drug Research
AbbVie to Assume Full Development and Commercial Control of Cystic Fibrosis Research Program
AbbVie ,a research-based global biopharmaceutical company, announced that it will assume full development and commercial responsibility for its collaboration with Galapagos to discover and...
Press Releases
Shionogi Announces FDA Approval of XOFLUZA for the Treatment of Acute, Uncomplicated Influenza
Shionogi & Co., Ltd. announced recently that, after completing a Priority Review, the USA FDA has approved XOFLUZA (baloxavir marboxil) for the treatment of...
Clinical Trials
REGENXBIO Announces Additional Positive Interim Phase I Trial Update for RGX-314
REGENXBIO Inc. a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology...
Press Releases
Thermo Fisher Scientific Announces Collaboration to Simplify Analysis of Complex Therapeutic Proteins
Thermo Fisher Scientific, the world leader in serving science, and Symphogen, a clinical-stage antibody oncology-focused company, have entered into a two-year collaborative partnership to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read